APO Research
Talk to an analyst

APO RESEARCH · REPORT

Formulas for Special Medical Purposes for Diabetes

Compare research editions
View pricing & licenses

Selected research

Industry Research

Formulas for Special Medical Purposes for Diabetes Industry Research Report 2026

27 December 2025134 pages

Choose your research edition.

Industry ResearchFormulas for Special Medical Purposes for Diabetes Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Formulas for Special Medical Purposes for Diabetes Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Formulas for Special Medical Purposes for Diabetes Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Formulas for Special Medical Purposes for Diabetes Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Formulas for Special Medical Purposes for Diabetes Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Formulas for Special Medical Purposes for Diabetes market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Formulas for Special Medical Purposes for Diabetes is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Formulas for Special Medical Purposes for Diabetes is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Formulas for Special Medical Purposes for Diabetes is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Formulas for Special Medical Purposes for Diabetes include Abbott Laboratories, Nestlé S.A., NUTRICIA, Fresenius, Ajinomoto, MeadJohnson, BOSSD, Bayer and EnterNutr, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Formulas for Special Medical Purposes for Diabetes market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Formulas for Special Medical Purposes for Diabetes Market by Company

Abbott Laboratories

Nestlé S.A.

NUTRICIA

Fresenius

Ajinomoto

MeadJohnson

BOSSD

Bayer

EnterNutr

Anhui New Health Biotechnology

Bangsidi Biotechnology

Dongze Special Medical Food

Special Biotechnology

Haisike Pharmaceutical

Xi'an Libang Clinical Nutrition

Formulas for Special Medical Purposes for Diabetes Segment by Type

Gel Food

Porous Food

Powdered Food

Pasty Food

Milky Food

Others

Formulas for Special Medical Purposes for Diabetes Segment by Application

Hospital

Pharmacy

Others

Formulas for Special Medical Purposes for Diabetes Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Formulas for Special Medical Purposes for Diabetes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Formulas for Special Medical Purposes for Diabetes and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Formulas for Special Medical Purposes for Diabetes.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Formulas for Special Medical Purposes for Diabetes manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Formulas for Special Medical Purposes for Diabetes by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Formulas for Special Medical Purposes for Diabetes in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Formulas for Special Medical Purposes for Diabetes Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Formulas for Special Medical Purposes for Diabetes Sales (k units) of Manufacturers (2021-2026) Table 7. Global Formulas for Special Medical Purposes for Diabetes Sales Market Share by Manufacturers (2021-2026) Table 8. Global Formulas for Special Medical Purposes for Diabetes Revenue of Manufacturers (2021-2026) Table 9. Global Formulas for Special Medical Purposes for Diabetes Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Formulas for Special Medical Purposes for Diabetes Average Price (USD/unit) of Manufacturers (2021-2026) Table 11. Global Formulas for Special Medical Purposes for Diabetes Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Formulas for Special Medical Purposes for Diabetes, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Formulas for Special Medical Purposes for Diabetes, Product Type & Application Table 14. Global Formulas for Special Medical Purposes for Diabetes Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Formulas for Special Medical Purposes for Diabetes by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Abbott Laboratories Company Information Table 19. Abbott Laboratories Business Overview Table 20. Abbott Laboratories Formulas for Special Medical Purposes for Diabetes Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 21. Abbott Laboratories Formulas for Special Medical Purposes for Diabetes Product Portfolio Table 22. Abbott Laboratories Recent Developments Table 23. Nestlé S.A. Company Information Table 24. Nestlé S.A. Business Overview Table 25. Nestlé S.A. Formulas for Special Medical Purposes for Diabetes Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 26. Nestlé S.A. Formulas for Special Medical Purposes for Diabetes Product Portfolio Table 27. Nestlé S.A. Recent Developments Table 28. NUTRICIA Company Information Table 29. NUTRICIA Business Overview Table 30. NUTRICIA Formulas for Special Medical Purposes for Diabetes Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 31. NUTRICIA Formulas for Special Medical Purposes for Diabetes Product Portfolio Table 32. NUTRICIA Recent Developments Table 33. Fresenius Company Information Table 34. Fresenius Business Overview Table 35. Fresenius Formulas for Special Medical Purposes for Diabetes Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 36. Fresenius Formulas for Special Medical Purposes for Diabetes Product Portfolio Table 37. Fresenius Recent Developments Table 38. Ajinomoto Company Information Table 39. Ajinomoto Business Overview Table 40. Ajinomoto Formulas for Special Medical Purposes for Diabetes Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 41. Ajinomoto Formulas for Special Medical Purposes for Diabetes Product Portfolio Table 42. Ajinomoto Recent Developments Table 43. MeadJohnson Company Information Table 44. MeadJohnson Business Overview Table 45. MeadJohnson Formulas for Special Medical Purposes for Diabetes Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. MeadJohnson Formulas for Special Medical Purposes for Diabetes Product Portfolio Table 47. MeadJohnson Recent Developments Table 48. BOSSD Company Information Table 49. BOSSD Business Overview Table 50. BOSSD Formulas for Special Medical Purposes for Diabetes Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 51. BOSSD Formulas for Special Medical Purposes for Diabetes Product Portfolio Table 52. BOSSD Recent Developments Table 53. Bayer Company Information Table 54. Bayer Business Overview Table 55. Bayer Formulas for Special Medical Purposes for Diabetes Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 56. Bayer Formulas for Special Medical Purposes for Diabetes Product Portfolio Table 57. Bayer Recent Developments Table 58. EnterNutr Company Information Table 59. EnterNutr Business Overview Table 60. EnterNutr Formulas for Special Medical Purposes for Diabetes Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 61. EnterNutr Formulas for Special Medical Purposes for Diabetes Product Portfolio Table 62. EnterNutr Recent Developments Table 63. Anhui New Health Biotechnology Company Information Table 64. Anhui New Health Biotechnology Business Overview Table 65. Anhui New Health Biotechnology Formulas for Special Medical Purposes for Diabetes Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. Anhui New Health Biotechnology Formulas for Special Medical Purposes for Diabetes Product Portfolio Table 67. Anhui New Health Biotechnology Recent Developments Table 68. Bangsidi Biotechnology Company Information Table 69. Bangsidi Biotechnology Business Overview Table 70. Bangsidi Biotechnology Formulas for Special Medical Purposes for Diabetes Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. Bangsidi Biotechnology Formulas for Special Medical Purposes for Diabetes Product Portfolio Table 72. Bangsidi Biotechnology Recent Developments Table 73. Dongze Special Medical Food Company Information Table 74. Dongze Special Medical Food Business Overview Table 75. Dongze Special Medical Food Formulas for Special Medical Purposes for Diabetes Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Dongze Special Medical Food Formulas for Special Medical Purposes for Diabetes Product Portfolio Table 77. Dongze Special Medical Food Recent Developments Table 78. Special Biotechnology Company Information Table 79. Special Biotechnology Business Overview Table 80. Special Biotechnology Formulas for Special Medical Purposes for Diabetes Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Special Biotechnology Formulas for Special Medical Purposes for Diabetes Product Portfolio Table 82. Special Biotechnology Recent Developments Table 83. Haisike Pharmaceutical Company Information Table 84. Haisike Pharmaceutical Business Overview Table 85. Haisike Pharmaceutical Formulas for Special Medical Purposes for Diabetes Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Haisike Pharmaceutical Formulas for Special Medical Purposes for Diabetes Product Portfolio Table 87. Haisike Pharmaceutical Recent Developments Table 88. Xi'an Libang Clinical Nutrition Company Information Table 89. Xi'an Libang Clinical Nutrition Business Overview Table 90. Xi'an Libang Clinical Nutrition Formulas for Special Medical Purposes for Diabetes Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Xi'an Libang Clinical Nutrition Formulas for Special Medical Purposes for Diabetes Product Portfolio Table 92. Xi'an Libang Clinical Nutrition Recent Developments Table 93. Global Formulas for Special Medical Purposes for Diabetes Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 94. Global Formulas for Special Medical Purposes for Diabetes Sales by Region (2021-2026) & (k units) Table 95. Global Formulas for Special Medical Purposes for Diabetes Sales Market Share by Region (2021-2026) Table 96. Global Formulas for Special Medical Purposes for Diabetes Sales by Region (2027-2032) & (k units) Table 97. Global Formulas for Special Medical Purposes for Diabetes Sales Market Share by Region (2027-2032) Table 98. Global Formulas for Special Medical Purposes for Diabetes Revenue by Region (2021-2026) & (US$ Million) Table 99. Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Region (2021-2026) Table 100. Global Formulas for Special Medical Purposes for Diabetes Revenue by Region (2027-2032) & (US$ Million) Table 101. Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Region (2027-2032) Table 102. North America Formulas for Special Medical Purposes for Diabetes Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. North America Formulas for Special Medical Purposes for Diabetes Sales by Country (2021-2026) & (k units) Table 104. North America Formulas for Special Medical Purposes for Diabetes Sales by Country (2027-2032) & (k units) Table 105. North America Formulas for Special Medical Purposes for Diabetes Revenue by Country (2021-2026) & (US$ Million) Table 106. North America Formulas for Special Medical Purposes for Diabetes Revenue by Country (2027-2032) & (US$ Million) Table 107. Europe Formulas for Special Medical Purposes for Diabetes Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Europe Formulas for Special Medical Purposes for Diabetes Sales by Country (2021-2026) & (k units) Table 109. Europe Formulas for Special Medical Purposes for Diabetes Sales by Country (2027-2032) & (k units) Table 110. Europe Formulas for Special Medical Purposes for Diabetes Revenue by Country (2021-2026) & (US$ Million) Table 111. Europe Formulas for Special Medical Purposes for Diabetes Revenue by Country (2027-2032) & (US$ Million) Table 112. Asia Pacific Formulas for Special Medical Purposes for Diabetes Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Asia Pacific Formulas for Special Medical Purposes for Diabetes Sales by Country (2021-2026) & (k units) Table 114. Asia Pacific Formulas for Special Medical Purposes for Diabetes Sales by Country (2027-2032) & (k units) Table 115. Asia Pacific Formulas for Special Medical Purposes for Diabetes Revenue by Country (2021-2026) & (US$ Million) Table 116. Asia Pacific Formulas for Special Medical Purposes for Diabetes Revenue by Country (2027-2032) & (US$ Million) Table 117. South America Formulas for Special Medical Purposes for Diabetes Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. South America Formulas for Special Medical Purposes for Diabetes Sales by Country (2021-2026) & (k units) Table 119. South America Formulas for Special Medical Purposes for Diabetes Sales by Country (2027-2032) & (k units) Table 120. South America Formulas for Special Medical Purposes for Diabetes Revenue by Country (2021-2026) & (US$ Million) Table 121. South America Formulas for Special Medical Purposes for Diabetes Revenue by Country (2027-2032) & (US$ Million) Table 122. Middle East and Africa Formulas for Special Medical Purposes for Diabetes Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Middle East and Africa Formulas for Special Medical Purposes for Diabetes Sales by Country (2021-2026) & (k units) Table 124. Middle East and Africa Formulas for Special Medical Purposes for Diabetes Sales by Country (2027-2032) & (k units) Table 125. Middle East and Africa Formulas for Special Medical Purposes for Diabetes Revenue by Country (2021-2026) & (US$ Million) Table 126. Middle East and Africa Formulas for Special Medical Purposes for Diabetes Revenue by Country (2027-2032) & (US$ Million) Table 127. Global Formulas for Special Medical Purposes for Diabetes Sales by Type (2021-2026) & (k units) Table 128. Global Formulas for Special Medical Purposes for Diabetes Sales by Type (2027-2032) & (k units) Table 129. Global Formulas for Special Medical Purposes for Diabetes Sales Market Share by Type (2021-2026) Table 130. Global Formulas for Special Medical Purposes for Diabetes Sales Market Share by Type (2027-2032) Table 131. Global Formulas for Special Medical Purposes for Diabetes Revenue by Type (2021-2026) & (US$ Million) Table 132. Global Formulas for Special Medical Purposes for Diabetes Revenue by Type (2027-2032) & (US$ Million) Table 133. Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Type (2021-2026) Table 134. Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Type (2027-2032) Table 135. Global Formulas for Special Medical Purposes for Diabetes Price by Type (2021-2026) & (USD/unit) Table 136. Global Formulas for Special Medical Purposes for Diabetes Price by Type (2027-2032) & (USD/unit) Table 137. Global Formulas for Special Medical Purposes for Diabetes Sales by Application (2021-2026) & (k units) Table 138. Global Formulas for Special Medical Purposes for Diabetes Sales by Application (2027-2032) & (k units) Table 139. Global Formulas for Special Medical Purposes for Diabetes Sales Market Share by Application (2021-2026) Table 140. Global Formulas for Special Medical Purposes for Diabetes Sales Market Share by Application (2027-2032) Table 141. Global Formulas for Special Medical Purposes for Diabetes Revenue by Application (2021-2026) & (US$ Million) Table 142. Global Formulas for Special Medical Purposes for Diabetes Revenue by Application (2027-2032) & (US$ Million) Table 143. Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Application (2021-2026) Table 144. Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Application (2027-2032) Table 145. Global Formulas for Special Medical Purposes for Diabetes Price by Application (2021-2026) & (USD/unit) Table 146. Global Formulas for Special Medical Purposes for Diabetes Price by Application (2027-2032) & (USD/unit) Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Formulas for Special Medical Purposes for Diabetes Distributors List Table 150. Formulas for Special Medical Purposes for Diabetes Customers List Table 151. Formulas for Special Medical Purposes for Diabetes Industry Trends Table 152. Formulas for Special Medical Purposes for Diabetes Industry Drivers Table 153. Formulas for Special Medical Purposes for Diabetes Industry Restraints Table 154. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Formulas for Special Medical Purposes for Diabetes Product Image Figure 5. Global Formulas for Special Medical Purposes for Diabetes Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Formulas for Special Medical Purposes for Diabetes Market Size (2021-2032) & (US$ Million) Figure 7. Global Formulas for Special Medical Purposes for Diabetes Sales (2021-2032) & (k units) Figure 8. Global Formulas for Special Medical Purposes for Diabetes Average Price (USD/unit) & (2021-2032) Figure 9. Gel Food Product Image Figure 10. Porous Food Product Image Figure 11. Powdered Food Product Image Figure 12. Pasty Food Product Image Figure 13. Milky Food Product Image Figure 14. Others Product Image Figure 15. Hospital Product Image Figure 16. Pharmacy Product Image Figure 17. Others Product Image Figure 18. Global Formulas for Special Medical Purposes for Diabetes Revenue Share by Manufacturers in 2025 Figure 19. Global Manufacturers of Formulas for Special Medical Purposes for Diabetes, Manufacturing Sites & Headquarters Figure 20. Global Top 5 and 10 Formulas for Special Medical Purposes for Diabetes Players Market Share by Revenue in 2025 Figure 21. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Formulas for Special Medical Purposes for Diabetes Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 23. Global Formulas for Special Medical Purposes for Diabetes Sales by Region in 2025 Figure 24. Global Formulas for Special Medical Purposes for Diabetes Revenue by Region in 2025 Figure 25. North America Formulas for Special Medical Purposes for Diabetes Market Size by Country in 2025 Figure 26. North America Formulas for Special Medical Purposes for Diabetes Sales Market Share by Country (2021-2032) Figure 27. North America Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Country (2021-2032) Figure 28. United States Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Canada Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Mexico Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Europe Formulas for Special Medical Purposes for Diabetes Market Size by Country in 2025 Figure 32. Europe Formulas for Special Medical Purposes for Diabetes Sales Market Share by Country (2021-2032) Figure 33. Europe Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Country (2021-2032) Figure 34. Germany Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. France Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. U.K. Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Italy Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Russia Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Spain Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Netherlands Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Switzerland Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Sweden Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Poland Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Asia Pacific Formulas for Special Medical Purposes for Diabetes Market Size by Country in 2025 Figure 45. Asia Pacific Formulas for Special Medical Purposes for Diabetes Sales Market Share by Country (2021-2032) Figure 46. Asia Pacific Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Country (2021-2032) Figure 47. China Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Japan Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. South Korea Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. India Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Australia Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Taiwan Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Southeast Asia Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Southeast Asia Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. South America Formulas for Special Medical Purposes for Diabetes Market Size by Country in 2025 Figure 56. South America Formulas for Special Medical Purposes for Diabetes Sales Market Share by Country (2021-2032) Figure 57. South America Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Country (2021-2032) Figure 58. Brazil Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Argentina Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Chile Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Middle East and Africa Formulas for Special Medical Purposes for Diabetes Market Size by Country in 2025 Figure 62. Middle East and Africa Formulas for Special Medical Purposes for Diabetes Sales Market Share by Country (2021-2032) Figure 63. Middle East and Africa Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Country (2021-2032) Figure 64. Egypt Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. South Africa Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Israel Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Türkiye Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. GCC Countries Formulas for Special Medical Purposes for Diabetes Revenue Growth Rate (2021-2032) & (US$ Million) Figure 69. Global Formulas for Special Medical Purposes for Diabetes Sales Market Share by Type (2021-2032) Figure 70. Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Type (2021-2032) Figure 71. Global Formulas for Special Medical Purposes for Diabetes Price (USD/unit) by Type (2021-2032) Figure 72. Global Formulas for Special Medical Purposes for Diabetes Sales Market Share by Application (2021-2032) Figure 73. Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Application (2021-2032) Figure 74. Global Formulas for Special Medical Purposes for Diabetes Price (USD/unit) by Application (2021-2032) Figure 75. Formulas for Special Medical Purposes for Diabetes Value Chain Figure 76. Formulas for Special Medical Purposes for Diabetes Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Formulas for Special Medical Purposes for Diabetes Industry Opportunities and Challenges

Scope & coverage.

Types
  • Gel Food
  • Porous Food
  • Powdered Food
  • Pasty Food
  • Milky Food
  • Others
Applications
  • Hospital
  • Pharmacy
  • Others
Companies covered
  • Abbott Laboratories
  • Nestlé S.A.
  • NUTRICIA
  • Fresenius
  • Ajinomoto
  • MeadJohnson
  • BOSSD
  • Bayer
  • EnterNutr
  • Anhui New Health Biotechnology
  • Bangsidi Biotechnology
  • Dongze Special Medical Food
  • Special Biotechnology
  • Haisike Pharmaceutical
  • Xi'an Libang Clinical Nutrition

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Formulas for Special Medical Purposes for Diabetes Market Size (2021-2032)
  4. 2.2.2 Global Formulas for Special Medical Purposes for Diabetes Sales (2021-2032)
  5. 2.2.3 Global Formulas for Special Medical Purposes for Diabetes Market Average Price (2021-2032)
  6. 2.3 Formulas for Special Medical Purposes for Diabetes by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Gel Food
  9. 2.3.3 Porous Food
  10. 2.3.4 Powdered Food
  11. 2.3.5 Pasty Food
  12. 2.3.6 Milky Food
  13. 2.3.7 Others
  14. 2.4 Formulas for Special Medical Purposes for Diabetes by Application
  15. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  16. 2.4.2 Hospital
  17. 2.4.3 Pharmacy
  18. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Formulas for Special Medical Purposes for Diabetes Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Formulas for Special Medical Purposes for Diabetes Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Formulas for Special Medical Purposes for Diabetes Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Formulas for Special Medical Purposes for Diabetes Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Formulas for Special Medical Purposes for Diabetes Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Formulas for Special Medical Purposes for Diabetes, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Formulas for Special Medical Purposes for Diabetes, Product Type & Application
  8. 3.8 Global Manufacturers of Formulas for Special Medical Purposes for Diabetes, Established Date
  9. 3.9 Global Formulas for Special Medical Purposes for Diabetes Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Abbott Laboratories
  2. 4.1.1 Abbott Laboratories Company Information
  3. 4.1.2 Abbott Laboratories Business Overview
  4. 4.1.3 Abbott Laboratories Formulas for Special Medical Purposes for Diabetes Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Abbott Laboratories Formulas for Special Medical Purposes for Diabetes Product Portfolio
  6. 4.1.5 Abbott Laboratories Recent Developments
  7. 4.2 Nestlé S.A.
  8. 4.2.1 Nestlé S.A. Company Information
  9. 4.2.2 Nestlé S.A. Business Overview
  10. 4.2.3 Nestlé S.A. Formulas for Special Medical Purposes for Diabetes Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Nestlé S.A. Formulas for Special Medical Purposes for Diabetes Product Portfolio
  12. 4.2.5 Nestlé S.A. Recent Developments
  13. 4.3 NUTRICIA
  14. 4.3.1 NUTRICIA Company Information
  15. 4.3.2 NUTRICIA Business Overview
  16. 4.3.3 NUTRICIA Formulas for Special Medical Purposes for Diabetes Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 NUTRICIA Formulas for Special Medical Purposes for Diabetes Product Portfolio
  18. 4.3.5 NUTRICIA Recent Developments
  19. 4.4 Fresenius
  20. 4.4.1 Fresenius Company Information
  21. 4.4.2 Fresenius Business Overview
  22. 4.4.3 Fresenius Formulas for Special Medical Purposes for Diabetes Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Fresenius Formulas for Special Medical Purposes for Diabetes Product Portfolio
  24. 4.4.5 Fresenius Recent Developments
  25. 4.5 Ajinomoto
  26. 4.5.1 Ajinomoto Company Information
  27. 4.5.2 Ajinomoto Business Overview
  28. 4.5.3 Ajinomoto Formulas for Special Medical Purposes for Diabetes Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Ajinomoto Formulas for Special Medical Purposes for Diabetes Product Portfolio
  30. 4.5.5 Ajinomoto Recent Developments
  31. 4.6 MeadJohnson
  32. 4.6.1 MeadJohnson Company Information
  33. 4.6.2 MeadJohnson Business Overview
  34. 4.6.3 MeadJohnson Formulas for Special Medical Purposes for Diabetes Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 MeadJohnson Formulas for Special Medical Purposes for Diabetes Product Portfolio
  36. 4.6.5 MeadJohnson Recent Developments
  37. 4.7 BOSSD
  38. 4.7.1 BOSSD Company Information
  39. 4.7.2 BOSSD Business Overview
  40. 4.7.3 BOSSD Formulas for Special Medical Purposes for Diabetes Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 BOSSD Formulas for Special Medical Purposes for Diabetes Product Portfolio
  42. 4.7.5 BOSSD Recent Developments
  43. 4.8 Bayer
  44. 4.8.1 Bayer Company Information
  45. 4.8.2 Bayer Business Overview
  46. 4.8.3 Bayer Formulas for Special Medical Purposes for Diabetes Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Bayer Formulas for Special Medical Purposes for Diabetes Product Portfolio
  48. 4.8.5 Bayer Recent Developments
  49. 4.9 EnterNutr
  50. 4.9.1 EnterNutr Company Information
  51. 4.9.2 EnterNutr Business Overview
  52. 4.9.3 EnterNutr Formulas for Special Medical Purposes for Diabetes Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 EnterNutr Formulas for Special Medical Purposes for Diabetes Product Portfolio
  54. 4.9.5 EnterNutr Recent Developments
  55. 4.10 Anhui New Health Biotechnology
  56. 4.10.1 Anhui New Health Biotechnology Company Information
  57. 4.10.2 Anhui New Health Biotechnology Business Overview
  58. 4.10.3 Anhui New Health Biotechnology Formulas for Special Medical Purposes for Diabetes Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Anhui New Health Biotechnology Formulas for Special Medical Purposes for Diabetes Product Portfolio
  60. 4.10.5 Anhui New Health Biotechnology Recent Developments
  61. 4.11 Bangsidi Biotechnology
  62. 4.11.1 Bangsidi Biotechnology Company Information
  63. 4.11.2 Bangsidi Biotechnology Business Overview
  64. 4.11.3 Bangsidi Biotechnology Formulas for Special Medical Purposes for Diabetes Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Bangsidi Biotechnology Formulas for Special Medical Purposes for Diabetes Product Portfolio
  66. 4.11.5 Bangsidi Biotechnology Recent Developments
  67. 4.12 Dongze Special Medical Food
  68. 4.12.1 Dongze Special Medical Food Company Information
  69. 4.12.2 Dongze Special Medical Food Business Overview
  70. 4.12.3 Dongze Special Medical Food Formulas for Special Medical Purposes for Diabetes Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Dongze Special Medical Food Formulas for Special Medical Purposes for Diabetes Product Portfolio
  72. 4.12.5 Dongze Special Medical Food Recent Developments
  73. 4.13 Special Biotechnology
  74. 4.13.1 Special Biotechnology Company Information
  75. 4.13.2 Special Biotechnology Business Overview
  76. 4.13.3 Special Biotechnology Formulas for Special Medical Purposes for Diabetes Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Special Biotechnology Formulas for Special Medical Purposes for Diabetes Product Portfolio
  78. 4.13.5 Special Biotechnology Recent Developments
  79. 4.14 Haisike Pharmaceutical
  80. 4.14.1 Haisike Pharmaceutical Company Information
  81. 4.14.2 Haisike Pharmaceutical Business Overview
  82. 4.14.3 Haisike Pharmaceutical Formulas for Special Medical Purposes for Diabetes Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Haisike Pharmaceutical Formulas for Special Medical Purposes for Diabetes Product Portfolio
  84. 4.14.5 Haisike Pharmaceutical Recent Developments
  85. 4.15 Xi'an Libang Clinical Nutrition
  86. 4.15.1 Xi'an Libang Clinical Nutrition Company Information
  87. 4.15.2 Xi'an Libang Clinical Nutrition Business Overview
  88. 4.15.3 Xi'an Libang Clinical Nutrition Formulas for Special Medical Purposes for Diabetes Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Xi'an Libang Clinical Nutrition Formulas for Special Medical Purposes for Diabetes Product Portfolio
  90. 4.15.5 Xi'an Libang Clinical Nutrition Recent Developments
5 Global Formulas for Special Medical Purposes for Diabetes Market Scenario by Region
  1. 5.1 Global Formulas for Special Medical Purposes for Diabetes Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Formulas for Special Medical Purposes for Diabetes Sales by Region: 2021-2032
  3. 5.2.1 Global Formulas for Special Medical Purposes for Diabetes Sales by Region: 2021-2026
  4. 5.2.2 Global Formulas for Special Medical Purposes for Diabetes Sales by Region: 2027-2032
  5. 5.3 Global Formulas for Special Medical Purposes for Diabetes Revenue by Region: 2021-2032
  6. 5.3.1 Global Formulas for Special Medical Purposes for Diabetes Revenue by Region: 2021-2026
  7. 5.3.2 Global Formulas for Special Medical Purposes for Diabetes Revenue by Region: 2027-2032
  8. 5.4 North America Formulas for Special Medical Purposes for Diabetes Market Facts & Figures by Country
  9. 5.4.1 North America Formulas for Special Medical Purposes for Diabetes Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Formulas for Special Medical Purposes for Diabetes Sales by Country (2021-2032)
  11. 5.4.3 North America Formulas for Special Medical Purposes for Diabetes Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Formulas for Special Medical Purposes for Diabetes Market Facts & Figures by Country
  16. 5.5.1 Europe Formulas for Special Medical Purposes for Diabetes Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Formulas for Special Medical Purposes for Diabetes Sales by Country (2021-2032)
  18. 5.5.3 Europe Formulas for Special Medical Purposes for Diabetes Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Formulas for Special Medical Purposes for Diabetes Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Formulas for Special Medical Purposes for Diabetes Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Formulas for Special Medical Purposes for Diabetes Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Formulas for Special Medical Purposes for Diabetes Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Formulas for Special Medical Purposes for Diabetes Market Facts & Figures by Country
  41. 5.7.1 South America Formulas for Special Medical Purposes for Diabetes Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Formulas for Special Medical Purposes for Diabetes Sales by Country (2021-2032)
  43. 5.7.3 South America Formulas for Special Medical Purposes for Diabetes Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Formulas for Special Medical Purposes for Diabetes Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Formulas for Special Medical Purposes for Diabetes Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Formulas for Special Medical Purposes for Diabetes Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Formulas for Special Medical Purposes for Diabetes Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Formulas for Special Medical Purposes for Diabetes Sales by Type (2021-2032)
  2. 6.1.1 Global Formulas for Special Medical Purposes for Diabetes Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Formulas for Special Medical Purposes for Diabetes Sales Market Share by Type (2021-2032)
  4. 6.2 Global Formulas for Special Medical Purposes for Diabetes Revenue by Type (2021-2032)
  5. 6.2.1 Global Formulas for Special Medical Purposes for Diabetes Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Formulas for Special Medical Purposes for Diabetes Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Formulas for Special Medical Purposes for Diabetes Sales by Application (2021-2032)
  2. 7.1.1 Global Formulas for Special Medical Purposes for Diabetes Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Formulas for Special Medical Purposes for Diabetes Sales Market Share by Application (2021-2032)
  4. 7.2 Global Formulas for Special Medical Purposes for Diabetes Revenue by Application (2021-2032)
  5. 7.2.1 Global Formulas for Special Medical Purposes for Diabetes Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Formulas for Special Medical Purposes for Diabetes Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Formulas for Special Medical Purposes for Diabetes Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Formulas for Special Medical Purposes for Diabetes Value Chain Analysis
  2. 8.1.1 Formulas for Special Medical Purposes for Diabetes Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Formulas for Special Medical Purposes for Diabetes Production Mode & Process
  5. 8.2 Formulas for Special Medical Purposes for Diabetes Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Formulas for Special Medical Purposes for Diabetes Distributors
  8. 8.2.3 Formulas for Special Medical Purposes for Diabetes Customers
9 Global Formulas for Special Medical Purposes for Diabetes Analyzing Market Dynamics
  1. 9.1 Formulas for Special Medical Purposes for Diabetes Industry Trends
  2. 9.2 Formulas for Special Medical Purposes for Diabetes Industry Drivers
  3. 9.3 Formulas for Special Medical Purposes for Diabetes Industry Opportunities and Challenges
  4. 9.4 Formulas for Special Medical Purposes for Diabetes Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst